©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Cyclic AMP and Chloride-dependent Regulation of the Apical Constitutive Secretory Pathway in Colonic Epithelial Cells (*)

(Received for publication, October 12, 1995; and in revised form, December 11, 1995)

Tamas Jilling (§) Kevin L. Kirk (¶)

From the Department of Physiology and Biophysics, Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama 35294-0005

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Epithelial cells of the colonic crypt engage in cAMP-mediated fluid and electrolyte secretion. In addition to participating in electrolyte transport, colonic crypt cells also synthesize and secrete a number of proteins and peptides that play a crucial role in mucosal homeostasis. In the present study we show that cAMP regulates not only electrolyte secretion but also polarized protein secretion in a tissue culture model of colonic crypt cells. We found that apical but not basolateral protein secretion was stimulated by a physiological activator of the cAMP pathway, vasoactive intestinal peptide, as well as by a cell-permeant analogue of cAMP (8-(4-chlorophenylthio)cAMP) at concentrations as low as 12.5 µM. Based on several criteria, we determined that the regulation of protein secretion by cAMP in HT29-CL19A cells occurs via stimulation of constitutive membrane traffic from the trans-Golgi network (TGN) to the apical cell surface. In addition, the regulation of apical protein secretion by cAMP was Cl-dependent with cAMP inhibiting rather than stimulating secretion in Cl-depleted cells. The locus of cAMP action on the secretory pathway is at least in part at the level of the TGN, where it stimulates the sialylation of alpha1-antitrypsin (i.e. one of the identified secretory proteins) in addition to the traffic of secretory proteins from the TGN to the apical cell surface. We propose that a cyclic AMP and Cl-dependent regulation of TGN acidification could modulate both sialylation and secretory vesicle budding at the TGN.


INTRODUCTION

Epithelial cells form a continuous barrier between the external environment (i.e. lumen) and interstitium while vectorially transporting ions, solutes, and macromolecules between these two compartments. These cells also vectorially secrete their own protein products; for example, epithelial cells composing the exocrine glands secrete specific secretory products (e.g. mucins and digestive enzymes) into the lumen. Nonglandular epithelial cells also secrete a number of ``housekeeping'' proteins (e.g. cytokines, protease inhibitors, components of the extracellular matrix, and antibacterial peptides) that protect and maintain the mucosa and serosa(1, 2, 3, 4, 5) . Two well defined classes of protein secretory pathways are utilized by epithelial as well as nonepithelial cells: (a) the regulated secretory pathway and (b) the constitutive pathway (for review see (6) ). The regulated secretory pathway involves the acute, stimulus-induced release of secretory material from a preformed storage compartment, such as the mucin storage granules of goblet cells(7) . Conversely, the constitutive secretory pathway lacks well defined storage granules and operates at a considerable basal level of activity. Constitutive membrane traffic pathways are also subject to regulation; e.g. there is accumulating evidence that the rate of constitutive membrane traffic from the Golgi apparatus to the cell surface can be modulated by regulatory factors such as heterotrimeric G proteins and protein kinases(8, 9, 10, 11, 12) . The molecular mechanisms and physiological stimuli underlying the protein kinase C-dependent regulation of constitutive secretion in rat basophilic leukemia cells have been partially characterized and involve the regulated binding of ARF (^1)to Golgi membranes(11) . Less is known about the regulatory role of cAMP-dependent protein kinase in constitutive membrane traffic. Apical membrane traffic in Madin-Darby canine kidney epithelial cells is stimulated by cAMP analogs but only at high concentrations (0.5-5 mM 8-Br-cAMP) (10) or in combination with high concentrations of phosphodiesterase inhibitors (500 µM 3-isobutyl-1-methylxantine)(8) . Unresolved issues include: (a) whether or not apical protein secretion can be stimulated by physiological activators of the cAMP-dependent protein kinase pathway (e.g. hormone receptors coupled to adenylate cyclase) in polarized epithelial cells and (b) the identities of the downstream effectors that mediate the stimulation of constitutive secretion by cAMP-dependent protein kinase.

In an earlier work we demonstrated that cAMP inhibits endocytosis and stimulates the recycling of previously internalized glycoproteins to the cell surface in pancreatic and intestinal epithelial cells that express wild type CFTR(13, 14) . Cells that were homozygous for the most common CFTR mutation (DeltaF508) lacked the regulation of either endocytosis or exocytosis by cAMP(14) . Because CFTR itself has been shown to enter the recycling pathway (15) and is present in clathrin-coated vesicles(16) , it has been postulated that CFTR modulates the recycling pathway via its function as a cAMP-regulated Cl channel within this pathway(15) . Given that a subset of recycling glycoproteins recycle through the TGN following their endocytosis from the cell surface(17, 18, 19) , it is conceivable that the recycling and biosynthetic pathways share common compartments and perhaps regulatory elements at the level of the TGN. On this basis we reasoned that cAMP (perhaps through CFTR) could regulate not only apical membrane recycling but also protein processing and polarized secretion along the biosynthetic pathway.

In order to assess the role of cAMP in regulating the biosynthetic pathway, we measured polarized protein secretion by colonic epithelial cells (T and HT29-CL19A) cultured on permeable supports, characterized the cargo within the apical and basolateral secretory pathways, and determined the effects of cAMP both on polarized secretion and on protein sialylation. We demonstrate that cAMP regulates apical but not basolateral protein secretion by these cells in a dose-dependent manner. The apical secretion by colonic epithelial cells is at least an order of magnitude more sensitive to cAMP analogues than that described for Madin-Darby canine kidney cells and is regulated by a physiological stimulator of the cAMP second messenger system (i.e. VIP). One of the proteins secreted by HT29-CL19A cells was identified as alpha1 antitrypsin, which is secreted at both the apical and basolateral surfaces. Based on several criteria, we determined that the secretion of AT from HT29-CL19A cells takes place primarily via the constitutive pathway and that cAMP facilitates the delivery of AT from the TGN to the apical cell surface. In addition, when Cl was replaced by gluconate, a nonpermeant anion, the regulation was reversed, i.e. cAMP inhibited apical protein secretion. Finally, we observed that cyclic AMP also stimulates the rate of AT sialylation within the biosynthetic pathway, indicating that the TGN is at least one site of action for cAMP. We discuss how CFTR, a cAMP-regulated Cl channel that has been implicated in the acidification of the TGN and in the regulation of membrane recycling, may be involved in the cAMP-dependent regulation of protein sialylation and apical protein secretion in colonic epithelial cells.


EXPERIMENTAL PROCEDURES

Materials

Tissue culture media were from Life Technologies, Inc., and defined fetal bovine serum (FBS) was from Hyclone (Logan, UT). Acrylamide, bis-acrylamide, ammonium persulfate, TEMED, urea, beta-mercaptoethanol, and ampholytes were from Bio-Rad. Protein G immobilized on agarose beads was from Boehringer Mannheim. Dialyzed FBS was prepared by dialyzing FBS against 100 volumes of phosphate-buffered saline overnight at 4 °C in dialysis bags (Spectrapor; molecular weight cut-off, 3,500) followed by sterile filtration. Tran-[S]-label was purchased from ICN (Costa Mesa, CA). Forskolin was from Calbiochem (La Jolla, CA), and Rp-8cpt-cAMPS was from Biolog (La Jolla, CA). ^14C-SDS-PAGE molecular weight markers were from Amersham Corp. All other chemicals were from Sigma.

Tissue Culture and Metabolic Labeling of Cells

HT29-CL19A cells were isolated as a clonal cell line that emerged from the parental HT29 cells following the induction of differentiation by treatment with butyrate(20) . HT29-CL19A cells represent a tissue culture model of nongoblet colonic crypt cells based on the fact that less than 1% are mucin positive cells(20) , the presence of cAMP-induced vectorial Cl transport, and high levels of CFTR expression(21) , i.e. hallmarks of the colonic crypt (22, 23) . T cells, another colonic cell line that we used for our studies, also exhibit a very small proportion of mucin-producing cells (5%)(24) , display similar ion transport properties, and also express CFTR(25, 26) . HT29-CL19A cells were maintained in Dulbeco's modified Eagle's medium (DMEM) supplemented with 10% FBS. T cells were cultured in 1:1 DMEM:F12 supplemented with 10% FBS. For all experiments cells were seeded onto Transwell filters (pore diameter, 0.4 µm; Costar); either 10^5 cells for filters of 6.5-mm diameter or 10^6 cells for filters of 24.5-mm diameter. Electrical resistance was monitored using ``chopstick'' electrodes and a high impedance ohmmeter (Millipore). Cells were typically used for experiments between 10 and 20 days following seeding at which time the electrical resistances were at 600 ohmsbulletcm^2 or higher. For metabolic labeling, cells were incubated in a CO(2) incubator at 37 °C in methionine and cysteine-free DMEM supplemented with 5% dialyzed FBS for 30 min followed by treatment with Tran-[S]-label in methionine- and cysteine-free DMEM/5% dialyzed FBS for an additional 30 min. Tran-[S]-label was added to the basolateral side only; 50 µCi/100 µl volume for the 6.5-mm filters and 500 µCi/600 µl volume for the 24.5-mm filters.

Macroscopic Assay for the Secretion of Metabolically Labeled Proteins by Trichloroacetic Acid Precipitation and Scintillation Counting

Following metabolic labeling, cells were washed two times with phosphate-buffered saline supplemented with 0.1 mM CaCl(2) and 1 mM MgCl(2). 200 µl of DMEM + 10% FBS was then placed into both the apical and basolateral compartments with or without secretagogues. Both media samples were collected following various time periods and placed on ice. Apical samples were centrifuged at 2,000 times g for 2 min to remove any loose cells. When the chase was performed in the absence of serum, FBS (i.e. carrier) was added to samples to a final concentration of 10% (v/v) before trichloroacetic acid precipitation. Trichloroacetic acid was added to the apical and the basolateral samples to a final concentration of 10%. Following incubation for 20 min on ice, samples were centrifuged at 3,000 times g for 3 min, supernatants were discarded, and pellets were washed with 10% trichloroacetic acid. Finally, the media samples were centrifuged at 16,000 times g for 3 min, and the pellets were dissolved in 0.5 N NaOH. The radiolabeled proteins remaining in the cells were collected by cutting the filters from the filter cups and placing them into ice-cold 10% (w/v) trichloroacetic acid. Filter were then washed in 10% trichloroacetic acid followed by dissolving the cells in 0.5 N NaOH. Samples were counted using a Packard (Downers Grove, IL) scintillation counter. Secretion was expressed as (media counts/cell counts) times 100 (i.e. the percentage of radiolabeled proteins released).

SDS-PAGE Analysis of the Secreted Proteins

For SDS-PAGE analysis, filters were labeled as above and washed twice with phosphate-buffered saline supplemented with 0.1 mM CaCl(2) and 1 mM MgCl(2). 30 µl of DMEM without serum was placed into each compartment either with or without secretagogues. In some experiments, the chase was performed in a modified Earle's buffered salt solution (MEBSS) (116 mM NaCl, 5.4 mM potassium acetate, 0.4 mM MgSO(4), 1.8 mM CaSO(4), 0.9 mM NaH(2)PO(4), 5.5 mM glucose, 4.9 mM sodium pyruvate, 26 mM NaHCO(3) in 5% CO(2) atmosphere) or in the same buffer but containing sodium gluconate instead of NaCl (MEBSS gluconate). Following the chase period, the media samples were collected and loose cells were removed from the apical samples as described above. 5 times SDS sample buffer (60 mM Tris (pH 6.8), 2%SDS, 5% beta-mercaptoethanol, 0.1% bromphenol blue, 50% glycerol) was then added to each sample followed by heating to 95 °C for 10 min. Samples and ^14C-methylated molecular weight markers were resolved on 8% T, 3% C SDS-PAGE gels, stained with Coomassie Blue, dried, and analyzed using a Molecular Dynamics PhosphorImager (Sunnyvale, CA). Phosphor image analysis was performed using IPlab Spectrum software (Signal Analytics, Vienna, VA) on a Macintosh IIci computer.

Immunoprecipitation of alpha1-Antitrypsin

Cell pellets were lysed at 4 °C for 60 min in RIPA buffer (50 mM Tris (pH 7.5), 24 mM sodium deoxycholate, 150 mM NaCl, 1% Triton X-100 (v/v), 0.1% SDS) supplemented with protease inhibitors (0.1 mg/ml aprotinin, 0.1 mg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride). Lysates were clarified by centrifugation at 16,000 times g for 4 min. Supernatants were precleared by treatment with protein G immobilized on agarose at 4 °C for 1 h. Precleared supernatants were then incubated with AT antibody or with an identical amount of nonimmune IgG for 90 min followed by incubation with immobilized protein G overnight. Immunoprecipitates were washed twice with RIPA buffer and solubilized in sample buffer either for SDS-PAGE or for one-dimensional IEF.

One-dimensional Isoelectric Focusing and Two-dimensional Polyacrylamide Gel Electrophoresis

For one-dimensional IEF, gels with a composition of 5% T, 3.3% C, 9 M urea, 1% (v/v) Biolyte 3/10, 4% Biolyte 5/7, 2% Triton X-100 were cast in minigel slabs (Bio-Rad). Immunoprecipitated AT was dissolved in a sample buffer containing 9 M urea, 1% (v/v) Biolyte 3/10, 4% Biolyte 5/7, 2% Triton X-100, 5% 2-mercaptoethanol and loaded onto the slab gel. Electrophoresis was performed at 5 watts constant power for 4 h and 8 watts constant power for 2 h using 20 mM NaOH as catholyth and 10 mM H(3)PO(4) as anolyth. Gels were fixed in 10% trichloroacetic acid, washed in 1% trichloroacetic acid, and dried prior to phosphor imaging. The first dimension of two-dimensional PAGE was performed using the aforementioned gel composition and the Mini-PROTEAN II tube system (Bio-Rad). Isoelectric focusing was performed at 300 V for 90 min, 500 V for 120 min, and 1000 V for 60 min. For the second dimension gel tubes were adapted briefly in 100 mM Tris (pH 6.8), 2% SDS, 5% 2-mercaptoethanol, and 8% glycerol and then subjected to SDS-PAGE using 8% T, 3% C gel slabs. Gels were stained, dried, and subjected to phosphor imaging or autoradiography.


RESULTS

General Considerations Regarding the Approach

In order to assess the regulation of polarized protein secretion by filter-grown cultures of colonic epithelial cells, we analyzed the secretion of metabolically pulse-labeled proteins by three different methods. First, labeled proteins that were secreted into either the apical or basolateral compartment, as well as labeled proteins retained within the cells, were trichloroacetic acid precipitated and quantified by scintillation counting. The rates of secretion were then calculated as the percentage of radiolabeled proteins released into either compartment as a function of time. This technique provided a macroscopic assay of the kinetics and regulation of apical and basolateral secretion. Second, the apical and basolateral media samples were directly analyzed by SDS-PAGE followed by phosphor imaging. This ``medium resolution'' technique provided an initial qualitative assessment of the cargo within the apical and basolateral secretory pathways and quantitative information regarding the secretion of individual protein bands. Third, we used a combination of two-dimensional gel electrophoresis, immunoprecipitation, and one-dimensional isoelectric focusing to identify specific proteins within the secretory pathway and to monitor protein processing in the biosynthetic pathway.

cAMP Stimulates Apical but Not Basolateral Protein Secretion

Fig. 1summarizes the results of our initial experiments performed using the macroscopic assay of polarized protein secretion. Both colonic cell lines behaved very similarly regarding the polarized secretion of metabolically labeled proteins analyzed with this method. Secretion exhibited linear kinetics throughout the 120-min chase period and the rate of basolateral secretion by both cell lines was severalfold greater than the apical secretion (Fig. 1, a and b). Secretion in both directions was abolished at 4 °C, as expected for a vesicle-mediated secretory process (Fig. 1b). When the chase was performed in the presence of cpt-cAMP (Fig. 1, a and b), the rate of apical secretion was stimulated significantly over baseline in both colonic cell lines. Forskolin, a direct activator of adenylate cyclase, also stimulated apical secretion by T cells (Fig. 1b). Basolateral secretion was unaffected by cyclic AMP in either of these two cell lines. Responsiveness to secretagogues was more consistent for HT29-CL19A cells (Fig. 1, error bars); accordingly, these cells were utilized for the more detailed analysis of the apical secretory pathway (see Fig. 2Fig. 3Fig. 4Fig. 5Fig. 6Fig. 7).


Figure 1: Regulation of polarized protein secretion as determined by trichloroacetic acid precipitation and scintillation counting. Macroscopic assay was performed as described under ``Experimental Procedures.'' The data shown are the percentages of incorporated label (i.e. cell-associated label) secreted as a function of time. circle, control; bullet, 800 µM cpt-cAMP; , 10 µM forskolin; times, 4 °C. Effect of forskolin on secretion by HT29-CL19A cells was not evaluated by this technique. a, HT29-CL19A; b, T cells.




Figure 2: a, electrophoretic profile of secreted proteins under control and stimulated conditions. Assay was performed as described under ``Experimental Procedures.'' Shown are duplicate samples for each condition. Molecular mass markers are shown in the middle (200, 97.4, 69, 46, or 30 kDa). Arrowheads, major protein bands (95 and 60 kDa) observed in both apical and basolateral samples; arrows, protein bands (105 and 120 kDa) limited to the basolateral samples; hollow arrowheads, protein bands (135 and >200 kDa) found only in apical samples. b, dose-response relationship between cpt-cAMP concentration and apical secretion. The percentage of stimulation was determined by measuring the change in intensity of the 60-kDa band on phosphor images of apical media samples. Shown is the mean ± S.E. of six determinations from three separate experiments (each performed in duplicate). c, the subarea indicated in b depicted at a higher resolution. Phosphor image analysis of the 95-kDa band revealed similar quantitative results; however, for simplicity and because the 60-kDa band was later identified as alpha1-antitrypsin, we show only the data regarding the 60-kDa band.




Figure 3: cAMP is a specific regulator of apical protein secretion by HT29-CL19A cells. a, phosphor image of the apically secreted 60-kDa band from a selected experiment shown along with corresponding densitometry data averaged from three separate experiments performed in duplicate (mean ± S.E., n = 6). The percentage of stimulation of the intensity of the 60-kDa band in the apical and basolateral media was assessed as described for Fig. 2. Individual data points were normalized to the mean intensity of the apical 60-kDa band determined for duplicate samples under control conditions. b, corresponding phosphor images and densitometry data of basolateral samples (mean ± S.E., n = 6). Basolateral data are also normalized to the apical control value to emphasize the differences in the baseline levels of apical and basolateral secretion. Asterisks indicate statistically significant differences from control (p < 0.0005). Lanes 1, control; lane 2, 200 µM cpt-cAMP added both apically and basolaterally; lane 3, 10 µM forskolin added both apically and basolaterally; lane 4, 100 nM VIP added basolaterally; lane 5, 100 nM VIP added apically; lane 6, 100 nM VIP added basolaterally along with 500 µM Rp-8cpt-cAMPS (i.e. a membrane-permeable, stereospecific inhibitory analog of cAMP) added to both sides.




Figure 4: Two-dimensional PAGE analysis of apically secreted proteins; alpha1-antitrypsin as the predominant secretory protein. The direction of the first dimension is indicated. Molecular markers mass were run in parallel (left side of panel, 200, 97.4, 69, 46, and 30 kDa). The arrow indicates the protein that corresponds to the 60-kDa protein observed on one-dimensional gels. Isoelectric point of this protein corresponds to 4.9-5.3 as determined by comparison with two-dimensional protein markers (Bio-Rad). The position and appearance of this protein is identical to the position and appearance of alpha1-antitrypsin secreted by HepG2 cells (Swiss 2D databank). The protein corresponding to the 95-kDa band (asterisk) has not been identified.




Figure 5: Linear kinetics and Ca independence of AT secretion in the absence or the presence of cAMP. a and b, representative data from one experiment are shown. Individual data points represent the intensity of the 60-kDa protein band determined by phosphor image analysis of apical (a) and basolateral (b) samples collected following various chase periods in the presence or the absence of cpt-cAMP (200 µM). Correlation coefficients from linear curve fitting: apical control R = 0.976, apical cAMP R = 0.979, basolateral control R = 0.965, basolateral cAMP R = 0.945. c, extracellular [Ca] and ionomycin (1 µM) have no effect on AT secretion. Shown are the normalized mean intensities of the 60-kDa apical band following 2 h of chase as determined by phosphor image analysis of duplicate samples from two experiments (mean ± S.E., n = 4). Individual data points were normalized to the mean intensity of the 60-kDa apical band determined for duplicate samples under control conditions. The presence (+) or the absence(-) of extracellular Ca (1 mM) during the chase is indicated.




Figure 6: The regulation of apical protein secretion by cAMP is dependent on the presence of Cl. Pulse labeling of the cells was followed by chase in DMEM (white bars), in MEBSS (black bars), or in MEBSS gluconate (hatched bars) in the presence or the absence of 200 µM cpt-cAMP as indicated. Phosphor image of the 60-kDa band from a selected experiment is shown with corresponding mean intensities of duplicate samples (mean ± S.D.).




Figure 7: cAMP stimulates the sialylation of AT. Pulse labeling and chase were performed at 20 °C to prevent traffic from the TGN to the cell surface. Immunoprecipitation and one-dimensional IEF of AT was performed as described under ``Experimental Procedures.'' a, IEF profiles of AT following the indicated chase periods (in hours) in the presence or the absence of 200 µM cpt-cAMP. b, corresponding densitograms. Top to bottom on the gels corresponds to left to right on the densitograms (i.e. alkaline, top/left; acidic, bottom/right). Only the sialylated forms of AT are shown on this figure, excluding the large signal associated with more alkaline forms (i.e. earlier glycosylation intermediates) of the molecule. The total immunoprecipitated signal (i.e. the signal shown on this figure plus the signal associated with less mature forms) was equal in all samples.



Our macroscopic secretion data suggested that protein secretion by colonic epithelial cells is polarized, because the rate of basolateral secretion was severalfold greater than apical secretion. However, this quantitative difference may simply reflect the greater basolateral surface area of these cells as observed by transmission electron microscopy (data not shown) rather than a qualitative difference in the nature of these pathways. In order to assess the profiles of apically and basolaterally secreted proteins and to obtain qualitative information regarding the polarity of secretion, the secretory products were analyzed by SDS-PAGE followed by phosphor imaging and densitometry. This analysis (Fig. 2a) revealed that protein secretion by HT29-CL19A cells is indeed qualitatively polarized. For example, major bands of 105 and 120 kDa were observed exclusively in the basolateral secretion (Fig. 2a, right, arrows), whereas several lower intensity bands were characteristic of the apical pathway (Fig. 2a, hollow arrowheads). Interestingly, in spite of the qualitatively distinct protein profiles of the apical and basolateral pathways, many bands were present in both, including two major bands corresponding to 60 and 95 kDa (Fig. 2a, solid arrowheads). Consistent with our macroscopic data, the apical but not basolateral secretion of the 60 and 95 kDa proteins increased in response to cpt-cAMP, as evidenced by the increased density of the corresponding bands on the phosphor images (Fig. 2a, left). The density of the 60-kDa band that appeared in the apical medium during a 2-h chase period increased by 2.5-fold (i.e. a 150% increase over the density of the apical control band) in the presence of 200 µM cpt-cAMP, as determined by phosphor image analysis (see Fig. 2b and Fig. 3a, second column). The stimulation by cAMP was not restricted to the 60-kDa protein but was generally observed for the majority of apically secreted proteins (Fig. 2a; see 95-kDa band and bands indicated by hollow arrowheads).

Fig. 2b illustrates that the rate of apical secretion was stimulated at cpt-cAMP concentrations as low as 12.5 µM. Shown is the dose-response relationship between the concentration of cpt-cAMP and the relative stimulation of secretion of the 60-kDa band (Fig. 2b). We observed a characteristic two-phase regulation of apical secretion by cAMP. In the first phase, concentrations of cpt-cAMP between 0-100 µM caused a 2-fold stimulation of secretion, plateauing at 50 µM (Fig. 2c). In the second phase, concentrations of cpt-cAMP greater than 100 µM resulted in additional stimulation of secretion that plateaued at approximately 500 µM cpt-cAMP and that corresponded to a nearly 4-fold stimulation over control values.

In order to document that cpt-cAMP stimulated apical protein secretion by a cAMP-specific mechanism, we utilized a panel of pharmacological mediators that act on the cAMP signaling pathway in different ways. Fig. 3summarizes our data regarding the pharmacological profile of regulation, as assessed by phosphor imaging and densitometry of the 60-kDa protein. 10 µM forskolin added to both sides or 100 nM VIP added to the basolateral side (i.e. to the side where its receptors are present) evoked increases in apical secretion similar in magnitude to that induced by 200 µM cpt-cAMP (see Fig. 3a). VIP added to the apical side had no effect, and the administration of 500 µM Rp-8-cpt-cAMPS, a cAMP-antagonist, abolished the effect of basolaterally administered VIP. The same treatments had no significant effects on the basolateral secretion of the 60-kDa protein (Fig. 3b). Given that the only common feature of these three agents is their ability to activate the cAMP signaling pathway, we conclude that cAMP is a specific regulator of apical protein secretion by HT29-CL19A cells.

Identification of the 60-kDa Secretory Protein as alpha1-Antitrypsin

In order to begin identifying some of the proteins secreted by HT29-CL19A cells, we analyzed the secreted proteins by two-dimensional PAGE and compared the results with the SWISS two-dimensional PAGE database(27) . The 60-kDa secreted protein was identified as AT, based on the characteristic appearance of its multiple sialylated forms, its isoelectric point, and its molecular weight (Fig. 4, arrow). This finding was verified by immunoprecipitation using specific antisera and relevant controls (data not shown). Two-dimensional PAGE analysis that was performed on both apically and basolaterally secreted proteins confirmed that AT as well as the 95-kDa protein (Fig. 4, asterisk) is secreted bidirectionally (only apically secreted proteins are shown). We also compared the apical secretions with or without stimulation by 200 µM cpt-cAMP by two-dimensional PAGE and failed to observe any novel protein species that were released by the cells as a consequence of cAMP stimulation (data not shown).

Apical Protein Secretion Exhibits Linear Kinetics and Is Ca-insensitive

In order to further characterize the apical secretory pathway that is regulated by cAMP in HT29-CL19A cells, we evaluated the time-course of secretion over an extended period of time and the Ca dependence of polarized protein secretion. Fig. 5(a and b) illustrates that AT secretion by HT29-CL19A cells follows a linear time course over 6 h in both the apical (Fig. 5a) and the basolateral (Fig. 5b) directions. In the presence of 200 µM cpt-cAMP, the basolateral rate of secretion was unchanged, whereas the same cpt-cAMP concentration elicited a sustained increase in the rate of apical AT secretion. Fig. 5c demonstrates that the Ca ionophore, ionomycin, had no effect on the apical secretion of AT either in the absence or in the presence of extracellular Ca. Ionomycin used at the same concentration evokes a robust potentiation of cAMP-induced Cl secretion by these cells (data not shown); thus, the inability of ionomycin to stimulate protein secretion in these cells is not due to a lack of effect on intracellular Ca activity. Neither ionomycin (data not shown) nor the removal of extracellular Ca (Fig. 5c) affected the extent of stimulation by cAMP. Furthermore, incubation of the monolayers with 20 µM BAPTA-AM for 60 min prior to metabolic labeling and during the subsequent labeling and chase periods did not affect either the polarity or the cAMP-dependent regulation of secretion (data not shown). Thus, apical protein secretion by HT29-CL19A cells and its regulation by cAMP are largely insensitive to intra- and extracellular [Ca].

Constitutive Apical Secretion in HT29-CL19A Cells Is Regulated by cAMP in a Cl-dependent Fashion

Because CFTR (i.e. a cAMP-regulated Cl channel) has been implicated in the regulation of apical membrane traffic (see the introduction), we also examined the Cl dependence of the effect of cAMP on apical protein secretion. Fig. 6demonstrates the results of a representative experiment in which the secretion assay was performed either in tissue culture medium (Fig. 6, white bars), a buffered salt solution containing Cl (Fig. 6, black bars), or the latter solution in which Cl was replaced by gluconate (Fig. 6, hatched bars), i.e. an anion that is poorly conducted by most Cl channels(28, 29, 30, 31) . A stimulation of apical secretion by cAMP was also observed when the assay was performed in a physiological buffer solution instead of tissue culture medium (Fig. 6, black bars). However, when the Cl in this buffer was replaced by gluconate, cAMP failed to stimulate secretion. Instead, cAMP inhibited apical protein secretion in Cl-depleted cells (Fig. 6, hatched bars).

Cyclic AMP Also Stimulates Protein Sialylation: Regulation at the TGN

Inhibition of TGN acidification results in reduced protein sialylation and in a reduced rate of constitutive protein secretion in HepG2 cells(32) . Because CFTR, a cAMP-regulated Cl channel, has been implicated in TGN acidification in those cells that express it(33, 34, 35, 36) , we reasoned that the regulation of constitutive secretion by cAMP in colonic epithelial cells could be related to a cAMP-dependent regulation of TGN acidification. AT sialylation can be used as an indirect indicator of acidification in the TGN, due to the close correlation between TGN acidification and the efficiency of sialylation(32) . In order to examine the effect of cAMP on the rate of sialylation in HT29-CL19A cells, we analyzed the extent of AT sialylation at 20 °C when newly synthesized AT is entrapped within the TGN(8, 37) , thus allowing the analysis of AT sialylation within a single intracellular pool. Fig. 7a demonstrates the results of a representative experiment in which AT was immunoprecipitated from cell lysates and analyzed by one-dimensional IEF. One-dimensional IEF allows the estimation of the extent of sialylation based on the pronounced acid shift in the isoelectric point of AT as a consequence of the addition of successive sialic acid residues. When the chase was performed in the presence of 200 µM cpt-cAMP, a shift toward the most acidic forms of AT was observed (compare second and fourth lanes of Fig. 7a). Fig. 7b shows densitograms corresponding to the second and fourth lanes of Fig. 7a (top to bottom on gels corresponds to left to right on densitogram). The pronounced increase in the density of bands representing the most acidic (i.e. sialylated) forms of AT in the cAMP-treated sample verifies that cAMP stimulates sialylation within the TGN of HT29-CL19A cells.


DISCUSSION

cAMP Regulates Constitutive Membrane Traffic from the TGN to the Apical Cell Surface

Our results indicate that cAMP regulates apical but not basolateral protein secretion in colonic epithelial cells. The specificity of this regulation by cAMP was documented using a panel of secretagogues including a physiological activator of the cAMP pathway (i.e. VIP), the stimulatory effect of which was blocked by a stereo-specific inhibitor of cAMP. The apical secretory pathway in colonic epithelial cells is at least an order of magnitude more sensitive to cAMP analogs than that reported for Madin-Darby canine kidney cells(8, 10) . It remains to be determined if this differential sensitivity of the biosynthetic pathway to cAMP is due to differences in cAMP metabolism or signaling between these cell types (e.g., differences in the expression levels of phosphodiesterase or cAMP-dependent protein kinase isoforms) or due to different downstream effector mechanisms.

On the basis of the following considerations we conclude that cyclic AMP regulates protein secretion by stimulating constitutive membrane traffic to the apical cell surface: (a) the linear kinetics of secretion under both control and stimulated conditions, (b) the insensitivity of secretion to Ca, a classical stimulator of regulated secretory pathways, and (c) the lack of accumulation of fully processed secretory material in well defined storage granules in these cells (data not shown). The observed stimulation of apical protein secretion by cAMP is not due to an elevated rate of protein synthesis, because that would have affected the basolateral rate of secretion. In addition, we determined that there is no further incorporation of radiolabeled amino acids into trichloroacetic acid precipitable material following the initial pulse period (i.e. during the time period when secretagogues are present; data not shown). The polarity of regulation indicates that TGN to apical cell surface traffic is at least one site of regulation by cAMP (i.e. there are no known polarized compartments within the biosynthetic pathway proximal to the TGN). This notion is also in agreement with the finding that the regulatory subunit (RII) of cAMP-dependent protein kinase associates with the TGN in epithelial cells(38) . A feasible mechanism by which cAMP could regulate constitutive membrane traffic is the stimulation of secretory vesicle formation at the TGN, similar to the regulation of constitutive secretion in rat basophilic leukemia cells by protein kinase C(11) . In rat basophilic leukemia cells the regulation of constitutive secretion by protein kinase C involves a stimulation of ARF binding to Golgi membranes that drives coat formation and vesicle budding from the Golgi(39) . AT secretion in HT29-CL19A cells is likely ARF-dependent, because we observed that brefeldin A (i.e. a drug that inhibits the exchange of guanine nucleotides bound to ARF(40) ) completely blocks protein secretion by HT29-CL19A cells (data not shown). Therefore, it is conceivable that mechanisms that regulate ARF binding to the TGN in a cAMP-dependent manner could modulate constitutive secretion in HT29-CL19A cells (see also below).

TGN Acidification as a Possible Mechanism Underlying the Regulation of Constitutive Secretion by Cyclic AMP

Both the rates of constitutive secretion and of AT sialylation have been shown to be dependent on TGN acidification in HepG2 cells. Namely, concanamycin B, an inhibitor of vacuolar ATPases, decreased the rate of AT secretion and sialylation in these cells(32) . The dependence of sialylation on TGN acidification is probably due in part to the acidic pH optimum of sialic acid transferase(41) ; however, the molecular mechanisms that link acidification to secretion are unknown. Interestingly, ARF binding to microsomal membranes in vitro has been shown to be dependent on vesicular acidification(42) . The acidification dependence of ARF binding to membranes could account for the inhibitory effect of concanamycin B on the rate of constitutive secretion in HepG2 cells and provides a feasible mechanism by which cAMP could regulate secretion (i.e. by regulating TGN acidification) in HT29-CL19A cells. Our observation of a stimulatory effect of cAMP on the rate of sialylation of AT that was entrapped in the TGN using a 20 °C temperature block is consistent with the notion that cAMP enhances TGN acidification in HT29-CL19A cells (see the connection between sialylation and acidification above). Vesicular acidification requires a mechanism to shunt the membrane potential generated by the vacuolar H-ATPase that otherwise limits the accumulation of protons. A Cl conductance of vesicular membranes can function as such a shunt mechanism, and a cAMP-regulated Cl conductance has been shown to regulate endosome acidification in kidney epithelial cells(43) . CFTR, a cAMP-regulated Cl channel, has been implicated in TGN acidification and in protein sialylation in epithelial cells(33, 35, 36) . Therefore, CFTR is a reasonable candidate for regulating TGN acidification in a cAMP-dependent manner in HT29-CL19A cells. The Cl dependence of the regulation of apical constitutive secretion by cAMP in HT29-CL19A cells that we observed is consistent with the role of a cAMP-regulated Cl channel in this regulation.

Possible Origins for the Polarity of Regulation

The TGN of normal rat kidney cells is composed of multiple tubules, as indicated by three-dimensional reconstruction of high voltage electron microscopy images. Each tubule corresponds to an already polarized entity, and all vesicles budding from a single tubule are coated with only one of two morphologically distinct coat structures observed in the TGN of these cells(44) . It cannot be determined from this morphological analysis whether membrane proteins destined for a single plasma membrane domain (i.e. apical or basolateral) of polarized epithelial cells are restricted to distinct tubules within the TGN. Nevertheless, if such a polarity exists within the TGN, then cAMP could selectively stimulate secretory vesicle budding from a TGN subcompartment that is dedicated to apical delivery. Such a mechanism would be consistent with a role for CFTR in this process, i.e. CFTR is targeted to the apical domains of HT29-CL19A cells(21) . Alternatively, if the budding of basolateral and apical secretory vesicles takes place from a common compartment within the TGN, the cAMP-dependent recruitment of a direction-specific cytosolic component to apically destined vesicles that are budding from the TGN could determine the polarity of regulation. The cytoskeletal motor protein, dynein, which has been shown to participate selectively in the apical delivery of transport vesicles, could be such a direction-specific cytosolic factor (45) . It remains to be determined if budding from an already polarized TGN domain, the recruitment of direction-specific cytosolic factors or both are responsible for the polarity of regulation of the constitutive secretory pathway by cyclic AMP.

Concluding Remarks

Our data demonstrate the existence of a high sensitivity, cAMP-dependent regulation of apical secretion by colonic epithelial cells. Thus, apical protein secretion and electrolyte and fluid secretion are regulated coordinately by cAMP in colonic crypt cells. We identified the predominant secretory product of HT29-CL19A cells as alpha1-antitrypsin and provided compelling evidence that the regulation of protein secretion by cAMP in these cells represents the stimulation of constitutive membrane traffic from the TGN to the apical cell surface. Our data are consistent with the notion that protein secretion via the constitutive secretory pathway takes place via the stimulation of constitutive vesicle generation (i.e. budding) from the TGN, in contrast to the regulation of secretory granule consumption (i.e. regulated exocytosis) by glandular cells. We propose that the regulation of protein sialylation and apical protein secretion by cAMP may have a common origin, i.e. regulated TGN acidification. This hypothesis is consistent with the genetic evidence that cyclic AMP-regulated CFTR Cl channels regulate protein sialylation and TGN acidification in epithelial tissues and is supported by the Cl dependence of the regulation of protein secretion. Defining the molecular basis for the regulation of protein processing and secretion by cyclic AMP, including the possible role of CFTR in this process, should contribute to our understanding of how polarized epithelial cells modulate mucosal homeostasis.


FOOTNOTES

*
This research was supported by Grant R464 PP#5 from the Cystic Fibrosis Foundation (to T. J.) and National Institutes of Health Grant DK50830 (to K. L. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: Dept. of Physiology and Biophysics, University of Alabama at Birmingham, 1918 University Blvd., Birmingham, AL 35294. Tel.: 205-934-3653; Fax: 205-934-1445.

Established Investigator of the American Heart Association during the course of this study.

(^1)
The abbreviations used are: ARF, ADP-ribosylation factor; VIP, vasoactive intestinal peptide; cpt-cAMP, 8-(4-chlorophenylthio)-adenosine 3`:5`-cyclic monophosphate; TGN, trans-Golgi network; CFTR, cystic fibrosis transmembrane conductance regulator; AT, alpha1 antitrypsin; PAGE, polyacrylamide gel electrophoresis; IEF, isoelectric focusing; FBS, fetal bovine serum; TEMED, N,N,N',N'-tetramethylethylenediamine; DMEM, Dulbecco's modified Eagle's medium; MEBSS, modified Earle's buffered salt solution; BAPTA-AM, 1,2-bis(o-aminophenoxy)-ethane-N,N,N`,N`-tetraacetic acid tetra(acetoxymethyl)-ester.


ACKNOWLEDGEMENTS

We thank Drs. David Bedwell, James Collawn, Eric Sorscher, and Edit Weber for reading the manuscript and providing helpful comments.


REFERENCES

  1. Eckmann, L., Jung, H. C., Schurrer-Maly, C., Panja, A., Morzycka-Wroblewska, E., and Kagnoff, M. F. (1993) Gastroenterology 105, 1689-1697 [Medline] [Order article via Infotrieve]
  2. Molmenti, E. P., Perlmutter, D. H., and Rubin, D. C. (1993) J. Clin. Invest. 92, 2022-2034 [Medline] [Order article via Infotrieve]
  3. Oguchi, S., Walker, W. A., and Sanderson, I. R. (1993) Biochem. Biophys. Res. Commun. 196, 789-793 [CrossRef][Medline] [Order article via Infotrieve]
  4. Sallenave, J.-M., Shulmann, J., Crossley, J., Jordana, M., and Gauldie, J. (1994) Am. J. Respir. Cell Mol. Biol. 11, 733-741 [Abstract]
  5. Venembre, P., Boutten, A., Seta, N., Dehoux, M. S., Crestani, B., Aubier, M., and Durand, G. (1994) FEBS Lett. 346, 171-174 [CrossRef][Medline] [Order article via Infotrieve]
  6. Bauerfeind, R., and Huttner, W. B. (1993) Curr. Opin. Cell Biol. 5, 628-635 [Medline] [Order article via Infotrieve]
  7. Lethem, M. I., Dowell, M. L., Scott, M. V., Yankaskas, J. R., Egan, T., Boucher, R. C., and Davis, C. W. (1993) Am. J. Respir. Cell Mol. Biol. 9, 315-322 [Medline] [Order article via Infotrieve]
  8. Hansen, S. H., and Casanova, J. E. (1994) J. Cell Biol. 126, 677-687 [Abstract]
  9. Pimplikar, S. W., and Simons, K. (1993) Nature 362, 456-458 [CrossRef][Medline] [Order article via Infotrieve]
  10. Pimplikar, S. W., and Simons, K. (1994) J. Biol. Chem. 269, 19054-19059 [Abstract/Free Full Text]
  11. De-Matteis, M. A., Santini, G., Kahn, R. A., Di-Tullio, G., and Luini, A. (1993) Nature 364, 818-821 [CrossRef][Medline] [Order article via Infotrieve]
  12. Mostov, K. E., and Cardone, M. H. (1995) BioEssays 17, 129-138 [Medline] [Order article via Infotrieve]
  13. Bradbury, N. A., Jilling, T., Kirk, K. L., and Bridges, R. J. (1992) Am. J. Physiol. 262, C752-C759
  14. Bradbury, N. A., Jilling, T., Berta, G., Sorscher, E. J., Bridges, R. J., and Kirk, K. L. (1992) Science 256, 530-532 [Medline] [Order article via Infotrieve]
  15. Prince, L. S., Workman, R. B., and Marchase, R. B. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 5192-5196 [Abstract]
  16. Bradbury, N. A., Cohn, J. A., Venglarik, C. J., and Bridges, R. J. (1994) J. Biol. Chem. 269, 8296-8302 [Abstract/Free Full Text]
  17. Green, S. A., and Kelly, R. B. (1990) J. Biol. Chem. 265, 21269-21278 [Abstract/Free Full Text]
  18. Huang, K. M., and Snider, M. D. (1993) J. Biol. Chem. 268, 9302-9310 [Abstract/Free Full Text]
  19. Bos, C. R., Shank, S. L., and Snider, M. D. (1995) J. Biol. Chem. 270, 665-671 [Abstract/Free Full Text]
  20. Augeron, C., and Laboisse, C. L. (1984) Cancer Res. 44, 3961-3969 [Abstract]
  21. Morris, A. P., Cunningham, S. A., Tousson, A., Benos, D. J., and Frizzell, R. A. (1994) Am. J. Physiol. 266, C254-C268
  22. Strong, T. V., Boehm, K., and Collins, F. S. (1994) J. Clin. Invest. 93, 347-354 [Medline] [Order article via Infotrieve]
  23. Welsh, M. J., Smith, P. L., Fromm, M., and Frizzell, R. A. (1982) Science 218, 1219-1221 [Medline] [Order article via Infotrieve]
  24. McCool, D. J., Marcon, M. A., Forstner, J. F., and Forstner, G. G. (1990) Biochem. J. 267, 491-500 [Medline] [Order article via Infotrieve]
  25. Bell, C. L., and Quinton, P. M. (1992) Am. J. Physiol. 262, C555-C562
  26. Denning, G. M., Ostedgaard, L. S., Cheng, S. H., Smith, A. E., and Welsh, M. J. (1992) J. Clin. Invest. 89, 339-349 [Medline] [Order article via Infotrieve]
  27. Appel, R. D., Sanchez, J.-C., Bairoch, A., Golaz, O., Ravier, F., Pasquali, C., Hughes, G. J., and Hochstrasser, D. F. (1994) Nucleic Acids Res. 22, 3581-3582 [Abstract]
  28. Kubo, M., and Okada, Y. (1992) J. Physiol. (Lond.) 456, 351-371
  29. Nilius, B., Sehrer, J., and Droogmans, G. (1994) Br. J. Pharmacol. 112, 1049-1056 [Abstract]
  30. Wang, X., Fedorko, L., Marunaka, Y., and O'Brodovich, H. (1993) Can. J. Physiol. Pharmacol. 71, 662-670 [Medline] [Order article via Infotrieve]
  31. Cunningham, S. A., Worrell, R. T., Benos, D. J., and Frizzell, R. A. (1992) Am. J. Physiol. 262, C783-C788
  32. Yilla, M., Tan, A., Ito, K., Miwa, K., and Ploegh, H. L. (1993) J. Biol. Chem. 268, 19092-19100 [Abstract/Free Full Text]
  33. Al-Awqati, Q., Barasch, J., and Landry, D. (1992) J. Exp. Biol. 172, 245-266 [Abstract/Free Full Text]
  34. Al-Awqati, Q. (1995) Curr. Opin. Cell Biol. 7, 504-508 [CrossRef][Medline] [Order article via Infotrieve]
  35. Barasch, J., Kiss, B., Prince, A., Salman, L., Gruenert, D., and Al-Awqati, Q. (1991) Nature 352, 70-73 [CrossRef][Medline] [Order article via Infotrieve]
  36. Barasch, J., and Al-Awqati, Q. (1993) J. Cell Sci. 17, (suppl.) 229-233
  37. Matlin, K. S., and Simons, K. (1983) Cell 34, 233-243 [Medline] [Order article via Infotrieve]
  38. Griffiths, G., Hollinshead, R., Hemmings, B. A., and Nigg, E. A. (1990) J. Cell Sci. 96, 691-703 [Abstract]
  39. Rosa, P., Barr, F. A., Stincombe, J. C., Binacchi, C., and Huttner, W. B. (1992) Eur. J. Cell Biol. 59, 265-274 [Medline] [Order article via Infotrieve]
  40. Helms, J. B., and Rothman, J. E. (1992) Nature 360, 352-354 [CrossRef][Medline] [Order article via Infotrieve]
  41. Solis, R. O. L., and Durham, J. P. (1983) Biochim. Biophys. Acta 729, 237-248 [Medline] [Order article via Infotrieve]
  42. Zeuzem, S., Feick, P., Zimmermann, P., Haase, W., Kahn, R. A., and Schulz, I. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6619-6623 [Abstract]
  43. Bae, H.-R., and Verkman, A. S. (1990) Nature 348, 637-639 [CrossRef][Medline] [Order article via Infotrieve]
  44. Ladinsky, M. S., Kramer, J. R., Furcinitti, P. S., McIntosh, J. R., and Howell, K. E. (1994) J. Cell Biol. 127, 29-38 [Abstract]
  45. Lafont, F., Burkhardt, J. K., and Simons, K. (1994) Nature 372, 801-803 [Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.